Researched applications In the published preclinical and clinical literature the effects of Cagrilintide are documented in the following areas: Obesity (stand-alone) , Phase 2 data (Lau 2021, 10.8 % at 4.5 mg) Obesity + Semaglutide (CagriSema) , Phase 3 REDEFINE 1 (25.3 %) T2DM + obesity , Phase 3 REDEFINE 2 Cardiovascular prevention , Phase 3 REDEFINE 3 (n ~ 7000) MASLD/MASH , exploratory in Phase 2 Type 2 diabetes (monotherapy) , preclinical data Prediabetes , exploratory plans Science & studies 4.1 Key publications Lau D.C.W., Erichsen L., Francisco A.M., et al
The relationship between obesity and asthma severity and control in adults
BPC-157 is characterized for its activity at angiogenic and NO signaling pathways, while TB-500 is studied for its role in actin dynamics and cell migration
Snchez-Bel P, Egea I, Snchez-Ballesta MT, Martinez-Madrid C, Fernandez-Garcia N, Romojaro F, Olmos E, Estrella E, Bolarn MC, Flores FB (2012) Understanding the mechanisms of chilling injury in bell pepper fruits using the proteomic approach
Kidney and Liver Function : Excessively high doses of glutathione over time could place stress on the liver or kidneys affecting their function significantly Increased Skin Cancer Risk: Long-term or high-dose glutathione IV therapy may suppress the melanin production in your skin raising the risk of skin cancer